Bioclinica Announces Breakthrough AI Image Redaction Technology for Clinical Trials
New solution offers pharmaceutical and biotech companies a powerful tool for video, photo, and PDF redaction, ensuring compliance and patient privacy
News provided by
Share this article
Share this article
PRINCETON, N.J., Jan. 19, 2021 /PRNewswire/ Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced a new product to support redaction of sensitive patient information from videos, photos, and PDFs in clinical trials. The addition of
Image Redact AI to Bioclinica s portfolio of specialty software solutions makes it the first and only company that can redact sensitive patient identifiers from videos in addition to photos and PDFs.